We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$224M
AUM Growth
+$26.5M
Cap. Flow
+$16.5M
Cap. Flow %
7.39%
Top 10 Hldgs %
27.71%
Holding
558
New
25
Increased
144
Reduced
58
Closed
2

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$256K
2
BUD icon
AB InBev
BUD
+$191K
3
GE icon
GE Aerospace
GE
+$138K
4
GILD icon
Gilead Sciences
GILD
+$108K
5
INTC icon
Intel
INTC
+$72.9K

Sector Composition

Rank Sector Weight
1 Healthcare 17.74%
2 Technology 16.33%
3 Financials 12.83%
4 Industrials 8.85%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BX icon
26
Blackstone
BX
$102B
$2.08M 0.93%
22,356
-650
-3% -$56.1K
HON icon
27
Honeywell
HON
$76.7B
$2.06M 0.92%
10,525
-21
-0.2% -$3.9K
META icon
28
Meta Platforms (Facebook)
META
$1.37T
$2M 0.89%
6,960
+1,085
+18% +$268K
LHX icon
29
L3Harris
LHX
$50.7B
$1.91M 0.86%
9,780
+3,070
+46% +$587K
V icon
30
Visa
V
$673B
$1.91M 0.85%
8,023
+325
+4% +$74.4K
SYY icon
31
Sysco
SYY
$40.6B
$1.86M 0.83%
25,116
+3,342
+15% +$247K
JNJ icon
32
Johnson & Johnson
JNJ
$617B
$1.81M 0.81%
10,913
+4,084
+60% +$659K
DE icon
33
Deere & Co
DE
$162B
$1.78M 0.79%
4,381
+454
+12% +$174K
TXN icon
34
Texas Instruments
TXN
$255B
$1.72M 0.77%
9,561
+1,683
+21% +$290K
XLI icon
35
State Street Industrial Select Sector SPDR ETF
XLI
$32.5B
$1.66M 0.74%
15,451
-175
-1% -$17.6K
NFLX icon
36
Netflix
NFLX
$305B
$1.65M 0.74%
37,420
+5,200
+16% +$192K
PANW icon
37
Palo Alto Networks
PANW
$265B
$1.65M 0.74%
12,898
+2,700
+26% +$281K
CVX icon
38
Chevron
CVX
$383B
$1.61M 0.72%
10,242
+47
+0.5% +$7.54K
COST icon
39
Costco
COST
$423B
$1.61M 0.72%
2,983
+175
+6% +$88.5K
IWF icon
40
iShares Russell 1000 Growth ETF
IWF
$120B
$1.52M 0.68%
22,112
CVS icon
41
CVS Health
CVS
$134B
$1.47M 0.66%
21,304
+453
+2% +$32.2K
XOM icon
42
ExxonMobil
XOM
$651B
$1.44M 0.64%
13,434
-222
-2% -$24.2K
BMY icon
43
Bristol-Myers Squibb
BMY
$132B
$1.34M 0.6%
20,952
-3,823
-15% -$256K
SYK icon
44
Stryker
SYK
$133B
$1.3M 0.58%
4,264
+685
+19% +$198K
VCSH icon
45
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.8B
$1.25M 0.56%
16,574
-498
-3% -$37.8K
VRP icon
46
Invesco Variable Rate Preferred ETF
VRP
$2.98B
$1.25M 0.56%
56,109
-1,661
-3% -$36.7K
VV icon
47
Vanguard Morningstar Large-Cap ETF
VV
$52.1B
$1.19M 0.53%
5,855
+2,025
+53% +$388K
XLP icon
48
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
$1.18M 0.53%
15,886
IJH icon
49
iShares Core S&P Mid-Cap ETF
IJH
$122B
$1.16M 0.52%
22,185
TSLA icon
50
Tesla
TSLA
$1.22T
$1.1M 0.49%
4,215
+375
+10% +$75K

Similar funds

Brown, Lisle/Cummings's Q2 2023 Portfolio in Review

As of Q2 2023, Brown, Lisle/Cummings held 558 positions worth $224M, up 13% from $197M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $16.5M of net new capital in Q2 2023, opening 25 new positions and adding to 144 existing holdings. Its largest new stake was Charles Schwab: 12,150 shares worth $689K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $256K trimmed.

  • Brown, Lisle/Cummings's largest Q2 2023 buy was Charles Schwab: 12,150 shares worth $689K.
  • Brown, Lisle/Cummings added most to Canadian National Railway in Q2 2023, an estimated $1.38M increase.
  • Brown, Lisle/Cummings's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $256K.
  • Brown, Lisle/Cummings fully exited J.M. Smucker in Q2 2023, selling an estimated $15.7K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $224M portfolio in Q2 2023.
  • Brown, Lisle/Cummings opened 25 new positions and closed 2 in Q2 2023.
  • Brown, Lisle/Cummings's portfolio value rose 13% quarter-over-quarter to $224M.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2023, filed 1 Jul 2024.